Stay updated on ImmuniCell® in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the ImmuniCell® in Advanced Cancers Clinical Trial page.

Latest updates to the ImmuniCell® in Advanced Cancers Clinical Trial page
- Check2 days agoChange DetectedA notice announces the NIH website transition and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. The content area shows the 403 message, replacing the usual study details and navigation.SummaryDifference17%

- Check58 days agoChange DetectedThe page now shows a new revision tag (v3.6.6) replacing the previous v3.6.5, signaling a minor update to the page’s versioning or rendering. This indicates an internal update without altering the study data or eligibility criteria.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5, representing a minor site version update. There are no changes to the study details or page content.SummaryDifference0.1%

Stay in the know with updates to ImmuniCell® in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImmuniCell® in Advanced Cancers Clinical Trial page.